STATCenter·
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
Read at STAT →
Health · 1 sources covering this
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/7446c944062eb84ca3fceeb3a261cd0e30b7cf53" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA"></iframe>
